GMP mutual recognition may help yearly 26.8 BW export growth.

The GMP mutual recognition between Korea and the U. S. under the KORUS FTA after 2011 may help yearly 26.8 billion won worth of the overseas drug export.

In the National Assembly hearing meeting the KFDA and KHIDI (Korea health industry development institute) said that 7 local drug companies were expected to satisfy far beyond the upgrade cost of c-GMP when the mutual recognition agreement o...